The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Celgene; Lilly; Merck Serono; Roche; Sanofi
Consulting or Advisory Role - Celgene; Lilly; Sanofi
Travel, Accommodations, Expenses - Celgene; Merck Serono; Roche; Sanofi
 
Consulting or Advisory Role - Amgen; Merck; Novartis; Pfizer; Roche
Speakers' Bureau - Merck
Research Funding - Merck; Roche
Time-course evaluation of survival and treatment in FIRE-3 (AIO KRK0306, first-line therapy of KRAS wild-type metastatic colorectal cancer with FOLFIRI plus cetuximab or bevacizumab).
 
Dominik Paul Modest
Honoraria - Amgen; Bayer; Merck; Roche
Consulting or Advisory Role - Amgen; Merck
Research Funding - Amgen; Merck; Roche
Travel, Accommodations, Expenses - Amgen; Merck; Roche; Sanofi
 
Sebastian Stintzing
Honoraria - Amgen; Bayer; Merck Serono; Roche/Genentech; Sanofi
Consulting or Advisory Role - Merck Serono; Roche
Travel, Accommodations, Expenses - Merck Serono; Roche/Genentech; Sanofi
 
Ludwig Fischer von Weikersthal
Travel, Accommodations, Expenses - Roche
 
Alberto F. Sobrero
Honoraria - Bayer; Celgene; Merck; Roche; Sanofi
Consulting or Advisory Role - Amgen; Bayer; Merck; Pfizer
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Merck; Sanofi
 
Thomas Decker
Honoraria - Novartis; Roche
Consulting or Advisory Role - Novartis
Speakers' Bureau - Novartis; Roche
 
Alexander Kiani
Honoraria - Amgen; Bristol-Myers Squibb; Merck; Novartis; Pfizer; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Pfizer
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Merck; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck; Novartis; Pfizer
 
Ursula Vehling-Kaiser
No Relationships to Disclose
 
Salah-Eddin Al-Batran
Consulting or Advisory Role - Celgene; Lilly; Merck; Roche
Speakers' Bureau - Celgene; Lilly; Nordic Bioscience; Roche
Research Funding - Celgene; Hospira; Lilly; Medac; Novartis; Roche Pharma AG; Vifor Pharma
 
Tobias Heintges
No Relationships to Disclose
 
Gernot Seipelt
Research Funding - Amgen; Celgene; Novartis; Roche/Genentech
Travel, Accommodations, Expenses - Ribosepharm
 
Christian A. Lerchenmuller
No Relationships to Disclose
 
Christoph Kahl
No Relationships to Disclose
 
Frank Kullmann
No Relationships to Disclose
 
Martina Stauch
No Relationships to Disclose
 
Werner Scheithauer
Honoraria - Amgen; Bayer; Merck; Roche
Consulting or Advisory Role - Merck; Roche
Research Funding - Merck; Roche
 
Swantje Held
No Relationships to Disclose
 
Markus H. Moehler
Honoraria - Amgen; Lilly/ImClone; Merck Serono; Roche/Genentech; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Amgen; Bayer; Merck Serono; Nordic Bioscience; Roche
 
Andreas Jung
Honoraria - Amgen; Celgene; GlaxoSmithKline; Merck; Pfizer; Roche
Consulting or Advisory Role - Amgen; Celgene; GlaxoSmithKline; Merck; Pfizer; Roche
Travel, Accommodations, Expenses - Amgen; Merck; Pfizer; Roche
 
Thomas Kirchner
No Relationships to Disclose
 
Volker Heinemann
Honoraria - Amgen; Bayer; Lilly; Merck KGaA; Roche; Sanofi; Sirtex Medical
Consulting or Advisory Role - Amgen; Lilly; Merck KGaA; Sanofi; Sirtex Medical
Speakers' Bureau - Amgen; Merck KGaA; Sanofi; Sirtex Medical
Research Funding - Amgen; Merck KGaA; Roche; Sirtex Medical
Travel, Accommodations, Expenses - Amgen; Merck KGaA; Roche; Sirtex Medical